Infermedica’s symptom checker – AI under the supervision of doctors

WROCLAW, POLAND – 09-14-2018 ( — Infermedica’s flagship app, Symptomate has received its biggest update to date. The latest version of the app provides high-quality information about various medical conditions, linked to articles from NHS Choices.

According to the studies, three out of four adults use the Internet to search for health information. Search results are often confusing. Infermedica believes there is a better way to get reliable and accurate informationInfermedica’s flagship app, Symptomate is the AI-powered app that helps users to easily assess their symptoms. Developed by a team of over 30 doctors, data scientists and software engineers, Symptomate has released the new iOS and Android apps and reached the next level.The app was launched in 2012 and has been used by three million people from 140 countries. Infermedica says that the AI-powered app works great on every mobile device and fits every screen.The underlying AI engine has been enhanced and now includes a broad medical database of 600 conditions and thousands of symptoms. “The release of all-new Symptomate is a huge milestone for our team,“ says Piotr Orzechowski, CEO of Infermedica. “As part of successful deployments with our insurance and hospital clients our app has undergone rigorous, clinical validation and has become the leading solution in the B2B market.”Also, Symptomate is now certified as a Class I Medical Device, as required by the European Union’s 93/68/EEC directive. This means that Symptomate is developed according to EU guidelines and legal requirements.“Our business model is all about customizing our technology to specific needs of health systems and insurance clients, and Symptomate is the showcase app that we invite you to try,” adds Piotr Orzechowski.The update comes with new language versions and now Symptomate supports 10 languages, including English, Spanish, Chinese, German, French, Italian, Brazilian Portuguese, Russian, Polish and Slovak.
Infermedica: Symptomate: app: app:

Media Contacts:

Company Name: Infermedica
Full Name: Tomasz Domino
Email Address: Send Email

For the original news story, please visit

Recommended For You


About the Author: Sarah Tulowitzki

Sarah Tulowitzki is a financial reporter, focusing on technology, national security, and policing. Before joining Canadian Business Tribune she worked as a staff writer at Fast Company and spent two years as a foreign correspondent in Turkey. Her work has been published in Al Jazeera America, The Nation, Vice News, Motherboard, and many other outlets.

Leave a Reply

Your email address will not be published. Required fields are marked *